Artificial pancreas to manage type 1 diabetes gets a trial run

September 14, 2017 by Natasha Strydhorst, Yale University
Artificial pancreas to manage type 1 diabetes gets a trial run
Wanda Faison, of the Eli Whitney staff, helps (from left) Gaven Martin, Jenna Stevens, and Summer Alba with their sailboats. During a week of activities, the youngsters tried out an artificial pancreas worn on their backs. Credit: Robert Lisak

Nine-year-old Summer Alba watched in rapt attention as the tour guide at the Yale Peabody Museum of Natural History animatedly outlined the profile of a bird-like dinosaur on a laminated sheet. As the guide described melanin and skin, one wonders whether Summer's attention returned to the pod attached to her own skin—visible on her upper arm, and perhaps nearly forgotten. She was one of five children (aged nine to 11 years) and one adult participating in a five-day clinical trial for a system to manage type 1 diabetes; the pod is a discreet insulin dispenser. The pediatric patients spent the days of the trial on outings around New Haven, including to the Peabody, where they heard about dinosaurs and handled—with mingled delighted disgust and fascination—fossilized dinosaur poop, a T-Rex tooth, and a Hadrosaur jawbone.

Summer, like all those diagnosed with type 1 diabetes, needs to keep careful track of her levels, controlling highs with doses of insulin and lows with snacks. Managing the disease is a never-ending numbers game with high stakes. To avoid organ damage from complications later in life, those with type 1 diabetes need to maintain their within a narrow margin—a balance maintained, sans disease, by the pancreas. It's a task of constant vigilance for patients—and, in the case of this pediatric cohort, their guardians.

"With this disease, you need as much simplicity as possible, because it's a very difficult rollercoaster, every day," said Michelle Alba, Summer's mother. The trial her daughter participated in is testing an "artificial pancreas," a hybrid closed-loop system of blood sugar monitoring and insulin delivery. The simplicity Alba craves is encapsulated in two devices—one a monitor to measure blood sugar levels, the other a pump to deliver insulin—and their heretofore-lacking interaction.

"In the current clinical care, for the vast majority of patients who use technologies, those two devices don't speak together," said Jennifer Lynn Sherr, M.D., Ph.D. '11, associate professor in pediatrics (endocrinology) and principal investigator of the trial. In conventional pump therapy, patients receive a continuous dose of background insulin throughout the day. Patients also need to check their blood sugar levels and enter the amount of carbohydrates they plan to eat so that the pumps release a quick dose of insulin as needed. With the Insulet automated glucose control system the monitor and pump communicate, meaning Summer receives additional insulin as her blood sugar level rises, and the system will cut back delivery as the level drops without her having to lift a finger.

"It's not like you slap on some devices and never have to worry about having diabetes again," Sherr cautioned. "It's automating some of the process." Patients using the Insulet automated glucose control system still need to check their glucose monitors and administer a larger dose of insulin before eating a meal.

The current trial is a result of efforts by myriad researchers and supporters—efforts stretching back decades. "One of the things that I think is really important to realize is just how many people go into making all of this happen," Sherr said. "We have an amazing team, and without that team none of this could get done."

Yale has been at the vanguard of diabetes research for decades. Together with Robert Sherwin, M.D., CNH Long professor of medicine (endocrinology), William Tamborlane, M.D., professor of pediatrics (endocrinology), orchestrated the first clinical trial of an insulin pump at Yale in 1979. Before that, the disease was managed by frequent injections of insulin. The pump was an innovation, delivering doses instead through a device that was always connected to the body—physically, that is—the wireless connection between the present system was still decades away. Tamborlane played a role in testing the continuous glucose monitor (approved in 1999) that has helped decrease the need for finger pricks.

Artificial pancreas to manage type 1 diabetes gets a trial run
Jenna Stevens and Summer Alba made sailboats at the Eli Whitney Museum while they tried out a new artificial pancreas. Credit: Robert Lisak

Insulet's automated glucose controller is the second hybrid closed-loop system tested at Yale. The other, developed by Medtronic, uses a tubed pump (different from the tube-free pod pump Summer wore on her upper arm) that obtained FDA approval last September. These systems are anticipated to improve control and convenience for those with type 1 diabetes—a diagnosis shared by some 35 million people around the world.

Sherr is intimately familiar with the daily struggles of her patients and their parents—she has type 1 diabetes herself. The diagnosis nudged her into medical ambition in her childhood. "At the age of nine, I could spell 'pediatric endocrinologist,'" she said, "and I was telling people that's what I was going to end up doing." She has also participated, as a patient, in previous clinical trials. "I have a better understanding of what I'm asking participants to do, and I can tell them, 'I've gone through it myself.'"

Like her patients, Sherr has a lifelong acquaintance with the balancing act that defines diabetes management. "It's such a tightrope people are walking, in terms of wanting to do their best, and yet being scared that something disastrous can occur," she said. For diabetes patients, nighttime—when low blood sugar levels can occur—can be worrisome. If a is prolonged it can lead to seizures. Given these concerns, some patients allow their blood sugars to remain above target, decreasing their anxiety about sleeping, but paradoxically increasing their risk for long term complications.

"I haven't slept well in four years," said Brenda Ramos, a school nurse whose son participated in the study. Her son, she said, was now steady all night. "The fact that the machine is thinking for you, and it catches things before they happen—it knows where his blood sugar's going before you actually see it. I think that's just amazing," she said.

Alba shared Ramos' enthusiasm. "I cried because I was so happy last night," she said. "A few times I just couldn't believe what a great day we had—because it's not like that for type ones. Ever." For the participants and their guardians, the real trial is daily life.

"They become different kids, with the disease," Michelle Alba said. "They become older than what they are, because they have to be so responsible about so many things."

Like most of her fellow participants, Summer's first talking point about the trial revolves around her numbers. "I've never been steady in the 100s [the optimal blood sugar range]—I've always been going low—so this has never happened," said Summer. "We think this is amazing that this is happening."

Explore further: First-generation 'artificial pancreas' brings hope for people with type 1 diabetes

Related Stories

First-generation 'artificial pancreas' brings hope for people with type 1 diabetes

July 14, 2017
A new "artificial pancreas" being studied by the University of Melbourne could dramatically transform the lives of people with type 1 diabetes.

Artificial pancreas improves blood sugar control in young kids

April 3, 2017
An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented ...

Artificial pancreas benefits young children, trial shows

April 28, 2017
A pilot study among young children with Type 1 diabetes found that a University of Virginia-developed artificial pancreas helped study participants better control their condition.

Taking a vacation from diabetes: Teens take 'artificial pancreas' for a test run

May 1, 2015
This weekend a group of teenagers will test an "artificial pancreas" in a real-world environment. Although Yale has been studying these devices for the last decade, this is the first time one will be tested in pediatric patients ...

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.